Microarray technology was evaluated for usefulness in assessing relationships between serum corticosterone and hepatic gene expression. Nine pairs of female Swiss mice were chosen to provide a wide range of serum corticosterone ratios; cDNA microarray analysis (∼8000 genes) was performed on their livers. A statistical method based on calculation of 99% confidence intervals discovered 32 genes which varied significantly among the livers. Five of these ratios correlated significantly with serum corticosterone ratio, including tyrosine aminotransferase, stress-induced protein, pleiotropic regulator 1 and insulin-like growth factor-binding protein-1; the latter has a potential role in cancer development. Secondly, linear regression of gene expression vs corticosterone ratios was screened for those with r ≥ 0·8 (P<0·01), yielding 141 genes, including some known to be corticosterone regulated and others of interest as possible glucocorticoid targets. Half of these significant correlations involved data sets where no microarray ratio exceeded±1·5. These results showed that microarray may be used to survey tissues for changes in gene expression related to serum hormones, and that even small changes in expression can be of statistical significance in a study with adequate numbers of replicate samples.
Introduction
Glucocorticoids are well known to regulate the expression of numerous genes in liver for control of energy metabolism, in response to stress, and as part of other physiological processes. In the past, these regulatory events have been revealed by experimental manipulation in vivo through ablation or hormonal supplementation studies, and by hormone treatment of hepatic cells in culture. In general, such investigations have involved large changes in hormone levels and hence pertain particularly to gene responses under extreme conditions. Fewer studies have been carried out to find changes in gene expression that occur in liver during the hourly fluctuations in circulating glucocorticoids that accompany diurnal rhythms, varying physical activity levels, and feeding. Also, there have been no comprehensive assessments of the total number and nature of the hepatic genes that may be influenced by glucocorticoids.
As a first step in gathering information on these topics, we have undertaken microarray analysis of normal mouse liver genes with a set of approximately 8000 cDNAs, and have correlated gene expression ratios with ratios of levels of serum corticosterone. Mice were analyzed in pairs, chosen on the basis of differing serum corticosterone; microarray analysis of gene expression was carried out for each liver. The ratio of serum corticosterone for the pair was then matched with the ratio of expression of each hepatic gene for that pair, for xy plotting of corticosterone ratio vs hepatic gene expression ratio. With nine pairs of livers, we found significant (P,0·01) correlations between serum corticosterone and microarray ratios for 141 genes. Some of these genes are known to be glucocorticoid responsive, while others are revealed as potential glucocorticoid targets for the first time. Of particular interest was insulin-like growth factor-binding protein-1 (Igfbp1), which, of all the genes correlated with serum corticosterone, showed the widest range of expression ratios. This protein plays a key role in regulating the actions of insulin-like growth factors (IGF)-I and -II, important contributors to growth control and cancer development (Wetterau et al. 1999) . The results with Igfbp1 were confirmed by both reverse transcription (RT)-PCR and real-time PCR. These studies have established, for the first time, the utility of microarray for relating serum parameters to gene expression in organs and establish a possible mechanism by which altered serum corticosterone could influence neoplasia development in multiple tissues.
Materials and methods

Animals and corticosterone analyses
Animals were maintained and handled in a facility fully accredited by the American Association for the Accreditation of Laboratory Animal Care, in accordance with the policies established by that organization and by National Institutes of Health (NIH) guidelines (Guide for the Care and Use of Laboratory Animals, NIH Publication No. 86-23 1985) . Female Swiss Cr:NIH(S) mice were bred from parents obtained from the Animal Production Area at the National Cancer Institute at Frederick. They were maintained on hardwood shavings as bedding, given NIH open formula autoclavable mouse chow (PMI, Inc., Richmond, IN, USA) and acidified water, under conditions of 72 7 C, 50 20% humidity, and a fluorescent light cycle of 12 h light:12 h darkness. The mice were killed by decapitation between 0930 and 1200 h. Preliminary studies showed that stress-related changes in serum corticosterone could be reduced by acclimatizing the mice to the laboratory and to brief handling before they were killed (not shown). Sera and livers were immediately frozen in liquid nitrogen and stored at 70 C until use. Total serum corticosterone was assayed by AniLytics, Inc. (Gaithersburg, MD, USA), utilizing a 125 I radioimmunoassay kit from ICN Biomedicals, Inc. (Irvine, CA, USA).
Liver samples were chosen so as to represent mice with a range of serum corticosterone values. In experiment 1, these values ranged from 25 to 740 ng/ml. Pairs for microarray analysis were selected so as to construct a wide range of serum corticosterone ratios, including eight that were uniformly distributed plus a lower extreme of 0·034 (pair 9 in Table 1 ). For the second confirmatory experiment assayed with real-time PCR, sera and livers were from an independent group of female mice of the same strain.
Microarray analysis
Total RNA was extracted from a sample of each liver by homogenization in the presence of Trizol (Life Technologies, Inc.). mRNA was isolated with oligo dT (Oligotex; Qiagen Co., Valencia, CA, USA). One microgram mRNA of each sample was submitted to Incyte Genomics, Inc. (Fremont, CA, USA) for the RT, microarray hybridization, and quantification process. ScanArray (Perkin Elmer Co., Wellsley, MA, USA) and GenePix Software (Union City, CA, USA) were used to acquire microarray image analysis and for quantification. Both endogenous and exogenous internal controls were included to monitor the quality and quantity of each array. Further information regarding Incyte Genomics may be found on the web site (www.incyte.com). Identifications of the Integrated Molecular Analysis of Genes and their Expression (I.M.A.G.E.) clones, used for preparation of the Incyte Genomics chips, were by reference of chip identification numbers to GenBank and dbEST, as of 15 April 2003. The reader is advised that definitive identification of some I.M.A.G.E. clones is still an evolving process.
Microarray data were downloaded from Incyte Genomics with a file transfer protocol to a Microsoft Windows NT 4·0 workstation equipped with GEMTools, a proprietary microarray analysis software from Incyte Genomics. Tab-delimited format microarray data files and pseudocolor plate-view PDF files were also downloaded from the company website. The data were prefiltered such that spots that were not at least 40% covered or that had a signal/background ratio less than 2·5 were omitted. Tab-delimited data files were imported to Microsoft Excel 97/2000 and to various mathematical and statistical packages for analysis.
The distribution of the data for each microarray pair was evaluated by the method of Chen et al. (1997) . Briefly, this method requires the calculation of a maximum likelihood estimate for the common coefficient of variation of the entire cDNA set. This method is used to specify the probability density function for the ratio of the set. Knowledge of this, in turn, enables one to calculate the lower and upper limits of a confidence interval (CI) for the array (Chen et al. 1997 , Powell et al. 2002 . As noted previously, by chance alone, only one cDNA of the 8000 assessed is expected to be found outside of the 99% CI in two array sets. It is highly unlikely that any given cDNA will occur outside of the 99% CI of three or more array sets. This strategy enabled us to identify genes whose apparent changes in expression were not due to chance alone.
As an additional analytical strategy, correlations of microarray ratios were sought with serum corticosterone ratios and with the logs of these ratios. In addition, corticosterone ratios less than one were converted to negative reciprocals, to parallel the representation of downregulated genes as negative values in the microarray. This format is referred to in this report as a reciprocal ratio. All three presentations of the corticosterone ratio data were tested for significant correlation with the expression of each of the 8000 genes in nine arrays. All genes with a correlation value of r=0·80 or better for any of the three corticosterone ratio data sets were selected. This corresponded to a significance of P=0·01 or better. There were 141 genes that met this criterion. Each of these genes was then examined separately for significance of the correlations by linear regression analysis. Each correlation was also tested for significance when the lower extreme value was omitted.
RT-PCR for Igfbp1
Specific IGF-binding protein-1 (Igfbp-1) primers (forward: ctctgcatgccctcacc and reverse: ccagcagctg ttcctct) were designed with Primer3 (www.genome. wi.mit.edu). The 18s RNA, amplified in parallel, served as an internal and amplification control. Synthesis of the first strand of cDNA was performed by the use of RETROScript (Ambion Corp.). A 20 µl reaction mixture, containing 2 µg total RNA, 100 U M-MLV RT, 1·25 µM random hexamers, 10 U placental RNase inhibitor, 0·5 mM dNTPs, 1·5 mM MgCl 2 , 50 mM KCl, and 10 mM Tris-HCl, pH 8·3, was incubated at 42 C for 1 h and then heated to 92 C for 10 min to denature the RT. An aliquot of 2 µl cDNA mixture was then amplified for the Igfbp and Classic 18S RNA internal amplification control (Ambion Quantum-RNA 18s RNA). The amplification reaction mixture consisted of 0·125 mM Tris-HCl, pH 8·3, 50 mM KCl, 1·5 mM MgCl 2 , 5 µM each forward and reverse primers, and 2·5 U Taq DNA polymerase (Ambion SuperTaq Plus) in a final volume of 50 µl. An RT-free reaction was run as a negative control. Optimum linearity conditions for the multiplex RT-PCR amplification along with 18s RNA were established (57 C, 25 cycles). PCR products were electrophoresed through a 10% polyacrylamide gel in Tris-borate-EDTA buffer. Bands were quantified with Sybr Green II (Molecular Probes, Inc., Eugene, OR, USA) and luminescence was measured in a digital image system (Alpha Innotech, IS-1000, San Leandro, CA, USA). The intensity of each band was normalized to the intensity of the corresponding 18s RNA control bands.
Real-time PCR for Igfbp1
Specific primers for real-time PCR quantification of Igfbp1 mRNA were designed using Primer Express software (Applied Biosystems, Forster City, CA, USA) and optimized for amplification and minimal primer dimer formation. Accurate quantification of Igfbp1 mRNA was achieved using a plasmid vector containing the mouse Igfbp1 cDNA obtained from the American Type Culture Collection (Manassas, VA, USA; I.M.A.G.E. no. 4161889). DNA sequencing from both the 5 and 3 ends verified identity. The real-time PCR assays for Igfbp1 plasmid DNA or cDNA were carried out in 20 µl reactions using primers (forward primer CTC TGC ATG CCC TCACC; reverse primer CCA GCA GCT GTT CCT CT) and SYBR Green master mix (Qiagen Inc.) and run on an ABI 8900 (Applied Biosystems, Inc., Foster City, CA, USA) for 40 cycles (95 C for 15 min, 95 C for 15 s, 60 C for 30 s; then a dissociation curve: 95 C for 15 s, 60 C for 15 s and then a 2% ramp rate to 95 C for 15 s). The standard, mouse glyceraldehyde-3-phosphate dehydrogenase (Gapdh) plasmid DNA was purchased from Serologicals (Gaithersburg, MD, USA). The real-time PCR assays for Gapdh plasmid DNA was carried out in 20 µl reactions using the mouse GAPDH control kit (Applied Biosystems) and run on an ABI 7900 for 40 cycles (95 C for 15 min, 95 C for 15 s, 60 C for 30 s, then a dissociation curve: 95 C for 15 s, 60 C for 15 s and then a 2% ramp rate to 95 C for 15 s. Sensitivity and linear dynamic range were checked on the serial dilutions (10 to 10 6 copies/reaction) of Igfbp1 and Gapdh plasmid DNA and found to be .98% efficient with a slope of 3·6. The Igfbp1 mRNA expression was normalized to the Gapdh expression in multiplex and quantified with its own standard curve, .97% efficiency with a slope of 3·8.
Results
Genes with significant among-pairs variation
The features of the nine pairs of mice used are given in Table 1 , including the absolute concentration of corticosterone in the serum and the serum corticosterone ratios for each pair. The last pair listed, with a corticosterone ratio of 0·03, is referred to as the 'lower extreme value' in the analyses which follow.
cDNA at 35 locations on the microarray chips showed a significant range in values among pairs, after application of the winnowing procedure based on the 99% confidence limits (see Materials and methods). Of these, 23 represented known genes. Two were present at two or more chip locations, providing confirmation of the results. Thus, expressions of 21 known genes showed significant variability among these normal livers, by this conservative statistical procedure.
Since the liver pairs had been selected on the basis of serum corticosterone, we next tested each of the 35 array ratios for significance of correlation with serum corticosterone ratios. Six were significant at P,0·05: one EST, one hypothetical protein, and Igfbp1, stress-induced protein, pleiotropic regulator 1, and tyrosine aminotransferase ( Table 2) . Microarray ratios for all of these genes were positively associated with serum corticosterone ratios, except for pleiotropic regulator 1, for which the correlation was negative.
Genes which showed significant expression variation among livers, but did not correlate with serum corticosterone, included metallothionein 1, lipin 1, presenilin 2, cytochrome P450 4a14, cytochrome P450 4a10, fatty acid synthase, aquaporin 1, macrophage activation protein 2, N-methyl-D-aspartate receptor-regulated gene 1, chloride intracellular channel 1 (mitochondrial), deleted in azoospermia-like, glutamate oxaloacetate transaminase 1, pancreatic colipase, aminolevulinic acid synthase 1, long chain fatty acyl elongase, and enolase 1, alpha non-neuron. Many of these showed wide ranges in array ratios among the nine liver pairs, from 5 to +5·8.
Gene expression ratios correlating with serum corticosterone
Additional correlations of gene expression with serum glucocorticoid were sought by linear regression analysis and selection of cDNAs with rd0·8 for the nine pairs, as related to corticosterone ratio, log of this ratio, or reciprocal ratios (see Materials and methods). A total of 141 genes met this criterion (Table 3) ; of these, 112 correlated positively with serum corticosterone, and 29 correlated negatively. Ratios of 83 genes, listed in Table 4 , maintained their significant correlation with corticosterone ratio when the lower extreme value was omitted; thus these showed correlation over a wide range of corticosterone values and ratios. These are designated category 1. The remaining 58 gene ratios (category 2; Table 5 ) correlated with corticosterone ratios only when the lower extreme value was included and so were most likely related to more marked differences in corticosterone. In both Tables 4 and 5 , the genes are presented in approximate rank order according to the magnitude of the array ratios. The clone location number indicates the position on the Incyte Genomics mouse cDNA microarray chip. The distribution of the data for each of the nine microarray pairs was evaluated by the method of Chen et al. (1997) , leading to calculation of the lower and upper limits of a 99% CI for the array. A total of 32 cDNAs at 35 chip locations presented array ratios which occurred outside the 99% CI for three or more data sets, a degree of variation with a very low probability of occurring by chance. The array ratios for each cDNA were examined by linear regression analysis for correlation with serum corticosterone ratios for the same animals. Of the 32 genes, five gene expression ratios correlated with serum corticosterone ratios; these results are shown above. The nine serum corticosterone ratios included eight that were spaced as a continuum over regular intervals, plus a ninth that was markedly lower; the latter is referred to as the lower extreme value. Gene array ratios were examined for correlation with the serum corticosterone ratios from the same animals, with a cut-off of r=0·8, ∼P=0·01. The set was queried with the corticosterone ratios calculated in three different ways: as a direct ratio, as a log of the direct ratio, and as a format where ratios <1·0 were utilized as reciprocals, to mimic the format of the array ratios. These processes yielded 141 significantly correlated genes. These were further subdivided into those that maintained a significant correlation even when the lower extreme value was omitted (category 1) and those that were significantly correlated only with inclusion of the lower extreme value (category 2). The majority of the genes in category 1 showed strongest correlation with absolute or, more frequently, log corticosterone ratios; only four correlated best with the reciprocal value (Table 3) . Most correlated positively, with seven showing a negative association (Table 4) . A convention in microarray analysis is to regard ratios of 1·5 as potentially significant. In category 1, 32 genes included at least one ratio 1·5; some of these genes are illustrated in Fig. 1 . The first two genes on the list, Igfbp1 and tyrosine amino transferase, had multiple gene ratios 2·0, and had accordingly also appeared on the list of significant changes based on the analysis presented in Table 2 . However, even genes with only one ratio value 1·5 showed highly significant correlations with serum corticosterone ratios, for example, pescadillo homologue 1 (P=0·0055), heterogeneous nuclear ribonucleoprotein A2/B1 (P=0·0019), cis retinol-androgen dehydrogenase (P=0·0043), proline oxidase 2 (P=0·0045), and histidine triad nucleotide-binding protein (P=0·0033) (Fig. 1 ). Of these, proline oxidase is known to be regulated by corticosterone (Kowaloff et al. 1977) . The heterogeneous nuclear ribonucleoprotein A2/B1 belongs to a class of molecules known to interact with the glucocorticoid receptor (Eggert et al. 2001) . Thus, correlations of expression of these genes with serum corticosterone are plausible.
Fifty-one genes in category 1 had no microarray ratio 1·5 (Table 4 ). In spite of presentation exclusively of low gene expression ratios, many of the correlations showed very highly significant correlations between cDNA ratios and serum corticosterone, as illustrated in Fig. 2 . Several of these are known to be regulated by glucocorticoids: nuclear factor of activated T cells (P=0·0028, not shown) (Refojo et al. 2001) , glutathione S transferase 3 (P=0·0019) (Falkner et al. 2001) , alcohol dehydrogenase 5 (P=0·0030) (Edenberg 2000) , and glucosidase 1 (P=0·0037, not shown) (Kalamidas & Kotoulas 2000) . The protein product of scavenger receptor class B (P=0·0063) has an important role in regulating plasma levels of cholesterol for use in glucocorticoid synthesis (Galman et al. 2002 , Malerod et al. 2002 . Category 2 genes included many correlating negatively with corticosterone ratios, and almost all showed strongest correlation when the reciprocal corticosterone ratio values were used (Table 3) . Fourteen genes in this class had more than one ratio 1·5 and/or one or more d 2·0 (Table 5) . Nevertheless, some genes with only one ratio 1·5 had very highly significant correlations between gene and corticosterone ratios (Fig. 3) , for example, interleukin 15 receptor (P=0·0001), fibroblast growth factor receptor (P,0·0001), nuclear factor, erythroid derived (P=0·0001), and programmed cell death 8 (P,0·0001). Genes in this group known to be influenced by glucocorticoids include fibroblast growth factor receptor (Riva et al. 1998 ) and the myeloblastosis oncogene, myb (Eastman-Reks & Vedeckis 1986). The clone location number refers to the position on the Incyte Genomics mouse cDNA microarray chip. For each cDNA, the array ratios for nine pairs of female mouse livers were plotted against the ratios of serum corticosterone levels for the same animals.
Those showing correlation at P<0·01 or better by linear regression analysis are listed, along with the direction of the correlation. The number of microarray ratios equal to or exceeding 1·5 and 2·0 are also shown. 
Continued
There were 24 genes in category 2 that showed no ratio 1·5. Several of these (Fig. 4) showed highly significant correlations, and are from families with known glucocorticoid regulation:
protein kinase A, regulatory, type 1 (P=0·0002) (Dwivedi & Pandey 2000) , interferon regulatory factor (P,0·0001) (Franchimont et al. 2000) , and cadherin 11 (P,0·0001) (Foty et al. 1998 ). The clone location number refers to the position on the Incyte Genomics mouse cDNA microarray chip. For each cDNA, the array ratios for nine pairs of female mouse livers were plotted against the ratios of serum corticosterone levels for the same animals.
Those showing correlation at P<0·01 or better by linear regression analysis are listed, along with the direction of the correlation. The number of microarray ratios equal to or exceeding 1·5 and 2·0 are also shown.
Figure 1
Representative genes showing significant correlation between microarray ratios and serum corticosterone (cort) ratios (or log corticosterone ratios), for category 1 genes with one or more gene pairs showing an array ratio of ±1·5 or greater. The correlation for category 1 genes was still significant when the lower extreme value was omitted.
Figure 2
Representative genes showing significant correlation between microarray ratios and serum corticosterone ratios (or log corticosterone ratios), for category 1 genes with no gene pairs showing an array ratio of ±1·5 or greater. The correlation for category 1 genes was still significant when the lower extreme value was omitted.
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Figure 3 Representative genes showing significant correlation between microarray ratios and serum corticosterone reciprocal ratios, for category 2 genes with one or more gene pairs showing an array ratio of ±1·5 or greater. The correlation for category 2 genes was not significant when the lower extreme value was omitted.
Confirmation of correlation of hepatic Igfbp1 expression with serum corticosterone levels
In order to confirm the striking correlation between gene expression ratios for Igfbp1 in liver with corticosterone ratios in serum, Igfbp1 mRNA levels were determined by semi-quantitative RT-PCR in the 18 liver samples. The ratios of these results correlated well with both microarray results (Fig. 5 , left panel) and with serum corticosterone ratios (Fig. 5, right panel) . In addition, to confirm the result with Igfbp1 further, livers and sera were analyzed from ten female mice of the same strain, but obtained at a different time. For this experiment, Igfbp1 message was quantified by real-time PCR. As illustrated in Fig. 6 (left panel), absolute levels of Igfbp1 message in liver correlated very strongly with serum corticosterone. Significant correlation was also observed when the values were normalized to Gapdh, though the scatter was greater (Fig. 6, right  panel) .
Discussion
The results of this investigation reveal several novel applications of microarray technology. The first is the discovery of genes showing marked, significant variation in expression in the livers of identically handled mice. There were 30 such genes, as listed in Table 2 . Six of these, including four known genes, correlated with serum corticosterone ratios for the same animals. Igfbp1 is known to be regulated by glucocorticoids (Lee et al. 1997 , Wetterau et al. 1999 , and tyrosine aminotransferase is so strongly glucocorticoid-responsive in liver that it is often used as a marker for the effects of these hormones (Granner & Hargrove 1983 , Ramakrishnan et al. 2002 . The stress-induced protein gene might be expected to be regulated by corticosterone, a stress hormone. Pleiotropic regulator 1 is a part of nuclear spliceosomes (Ajuh et al. 2001) and in Arabidopsis exercises pleiotropic control of glucose and steroid hormone responses (Nemeth et ; its regulation by glucocorticoids in mammals may not have been described.
A total of 23 genes, including 16 known genes, had significantly variable expression among the liver pairs for reasons not clearly related to serum corticosterone. Many of these code for enzymes involved in intermediary metabolism/catabolism. There were several others of possible interest in the context of individual variation in disease susceptibility. Lipin codes for a nuclear protein that plays a key role in nutrient sensing and adipocyte development (Peterfy et al. 2001 , Huffman et al. 2002 . Presenilin 2 contributes to Alzheimer's disease risk, and has been implicated in the processing of amyloid precursors (Edbauer et al. 2002) , control of apoptosis (Alves da Costa et al. 2002) , and protein synthesis (Gamliel et al. 2002) . Although presenilin is expressed in liver (Benkovic et al. 1997) , its function there has not been studied. The protein product of Clic4, a mitochondrial chloride channel protein, has been implicated in apoptotic response to DNA damage (FernandezSalas et al. 2002) . The water channel protein aquaporin 2 apparently is not expressed in rat liver (Umenishi et al. 1996 , Huebert et al. 2002 , but has not been studied in mice; it may have a role in glucose-driven water transport in liver (Masyuk et al. 2002) .
The reasons for the variability in the expression of these genes among this homogeneous group of mice will require more study. The contribution of genetics cannot be ruled out, since NIH Swiss mice are not inbred. However, inter-individual variation in physiological and biochemical hepatic parameters is commonly observed even among inbred animals. A practical conclusion from this aspect of the study is that the common practice of pooling two or three livers to obtain a common reference control sample for microarray studies could lead to erroneous conclusions for some genes.
The second new use for microarray was the survey of the 8000 genes for correlation between hepatic gene expression and serum corticosterone. Corticosterone regulation of gene expression has long been known and studied in cells, animals, and humans, often with molecular constructs and/or extreme variations in concentration. Our results show that it is possible to survey comprehensively changes in tissue gene expression as related to normal variations in serum corticosterone in untreated animals. Of particular interest here was the finding that, in most of the significant correlations, the majority of the microarray values did not exceed 1·5. Indeed, a total of 75 correlations, listed in Tables 3 and 4 , had no microarray ratio values greater than 1·5. Some of these correlations were very highly significant, and involved genes known to be regulated by corticosterone (see above). Heretofore, microarray ratios of , 1·5 have been regarded as noise by most investigators. Our results suggest that these small changes are in fact meaningful. A recent study of the familial adenomatous polyposis gene revealed that a 50% reduction in expression at the RNA level was sufficient to lead to development of polyposis (Yan et al. 2002) .
As noted above, many of the genes showing significant correlation with serum corticosterone in this study are already known to be glucocorticoid responsive, or at least from gene families with this characteristic. These results collectively confirm the validity of the experimental approach, and point to these genes as ones that are responsive to normal physiological variations in serum corticosterone. The other genes that correlated significantly with serum corticosterone ratios could be directly or indirectly associated. Many of these gene products are involved in metabolism and a relationship with corticosterone levels is not surprising. Also of interest are the numerous genes involved in cell growth control, that may have been revealed as glucocorticoid related for the first time. These are summarized in Table 6 . In all, significant correlations with serum corticosterone were found for four growth factor/receptor genes, 18 genes for extracellular, membrane and/or signaling proteins, 16 genes for products involved in transcription or gene expression control, and five genes related to cell cycle, DNA repair, or apoptosis.
The gene whose expression correlated most strikingly with serum corticosterone was Igfbp1. This gene is well known to be inducible through glucocorticoid response elements in the promoter in both human and rat liver cells (Suh et al. 1994 , Goswami et al. 1994 . It is reasonable to conclude that the Igfbp1 genes in the livers in our study were directly controlled by serum corticosterone, over a wide range of titers. However, insulin strongly suppresses Igfbp1 expression through a response element that interacts with the glucocorticoid control sequences (Robertson et al. 1994 , Suwanichkul et al. 1994 , and can override the inductive effects of glucocorticoids. It has become generally accepted that insulin is the major regulator of Igfbp1 expression, with glucocorticoids and other factors playing modulatory roles . Our results may be somewhat 
The known genes represented by the cDNAs in Tables 4 and 5 were searched using MedLine and LocusLink NCBI databases, for functions and for published reports indicating regulation by, or other relationship with, glucocorticoids. Genes with a likely relationship to cell growth control are listed. n/f, no references found.
surprising, therefore, in suggesting that corticosterone had a predominate role in the regulation of Igfbp1 expression. The suppressive effect of insulin has a concentration threshhold and under conditions of hypoinsulinemia in humans cortisol causes significant increase in plasma IGFBP-1 . Our mice were killed in the morning, when diurnal and mealrelated levels of insulin are expected to be low (Gagliardino & Hernandez 1971 , Petersen 1978 . Under these circumstances, corticosterone may provide the main control of Igfbp1 expression. IGFBP-1 is known to be upregulated by fasting, exercise, and various forms of stress , all situations involving marked elevations in serum corticosteroids. It is clear that regulation of Igfbp1 is complex and involves numerous signaling pathways and transcription factors (Neau et al. 1995 , Suh et al. 1995 , Lewitt et al. 1996 . Nevertheless, it may be that glucocorticoids often play a more primary role in the regulation of Igfbp1 expression than hitherto suspected, and in this way may influence cancer risk. Circulating levels of IGFBP-1 regulate the bioavailability of IGF-I and IGF-II, which can be growth factors for neoplastic cells; this axis is under study as a target for cancer prevention and treatment efforts (McCarty 1997 , Kari et al. 1999 , Yee 2002 ). In addition, direct effects of IGFBP-1 on tumors have been reported (Perks et al. 1999 , Zhang & Yee 2002 .
